INO
Inovio Pharmaceuticals Inc
NASDAQ: INO · HEALTHCARE · BIOTECHNOLOGY
$1.12
+0.00% today
Updated 2026-04-30
Market cap
$95.46M
P/E ratio
—
P/S ratio
1,460.95x
EPS (TTM)
$-1.81
Dividend yield
—
52W range
$1 – $3
Volume
1.8M
Inovio Pharmaceuticals Inc (INO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-7.04M | $-11.51M | $-11.13M | $-14.08M | $-11.94M | $-19.76M | $-22.31M | $-15.38M | $-29.82M | $-12.44M | $-62.56M | $-63.21M | $-73.55M | $-97.85M | $-177.98M | $-215.71M | $-216.22M | $-124.37M | $-104.08M | $-88.63M |
| Capital expenditures | $1.37M | $645730.00 | $583798.00 | $164935.00 | $306629.00 | $161187.00 | $240986.00 | $176925.00 | $1.38M | $2.78M | $3.94M | $10.29M | $2.09M | $987926.00 | $1.52M | $1.23M | $969153.00 | $320898.00 | $487832.00 | $285698.00 |
| Depreciation | $911643.00 | $954641.00 | $993027.00 | $1.68M | $2.11M | $2.01M | $1.99M | $2.10M | $1.57M | $1.92M | $3.09M | $3.47M | $5.00M | $5.52M | $4.63M | $4.73M | $5.50M | $3.50M | $3.13M | — |
| Stock-based comp | $1.40M | $1.70T | $1.14M | $2.16M | $1.17M | $1.65M | $1.35M | $1.87M | $5.43M | $6.19M | $10.48M | $13.07M | $10.65M | $10.90M | $15.65M | $26.34M | $22.56M | $11.07M | $6.60M | $3.76M |
| Free cash flow | $-8.41M | $-12.16M | $-11.71M | $-14.25M | $-12.24M | $-19.92M | $-22.55M | $-15.56M | $-31.20M | $-15.22M | $-66.49M | $-73.50M | $-75.64M | $-98.84M | $-179.50M | $-216.94M | $-217.18M | $-124.69M | $-104.56M | $-88.92M |
| Investing cash flow | $-16.07M | $-2.85M | $2.92M | $1.45M | $11.44M | $-10.90M | $5.28M | $-9.24M | $-35.81M | $-54.82M | $16.27M | $-27.83M | $42.42M | $-9.04M | $-58.80M | $-175.34M | $109.59M | $87.36M | $104.07M | — |
| Financing cash flow | $14.19M | $16.30M | $12.16M | $28.60M | $-9.69M | $28.01M | $5.33M | $52.69M | $72.46M | $84.35M | $7.79M | $95.69M | $31.04M | $105.40M | $465.28M | $211.50M | $81.84M | $5.00M | $51.48M | — |
| Dividends paid | $132343.00 | $23335.00 | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | $93.24M | $3.86M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $-2.65M | $-11.70M | $28.07M | $6.82M | $17.09M | $-38.50M | $4.65M | $-92946.00 | $-1.50M | $228.50M | $-179.55M | $-24.79M | — | — | — |